3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
30
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
3
Recurrence
2
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Hodgkin Disease
1
Interventions
Psychiatric Rehabilitation
6
Therapeutics
5
Polymerase Chain Reaction
5
Flow Cytometry
5
Surveys and Questionnaires
4
Respiratory Physiological Phenomena
3
Immunoenzyme Techniques
3
Blood Specimen Collection
3
Amplified Fragment Length Polymorphism Analysis
3
Watchful Waiting
2
RTEL1 protein, human
2
Microarray Analysis
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Gene Expression Profiling
2
Exercise Test
2
Database Management Systems
2
Brentuximab Vedotin
2
Valganciclovir
1
Spectroscopy, Near-Infrared
1
Specimen Handling
1
Range of Motion, Articular
1
Radiotherapy
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Patient Health Questionnaire
1
Inositol
1
Influenza Vaccines
1
In Situ Hybridization
1
Immunosuppression Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hodgkin Disease
×
Bendamustine Hydrochloride
×
Clear all
NCT07145125
2025-11-21
HL-R2-B2
University Hospital, Bordeaux
Completed
222 enrolled